At the 52nd annual meeting of the American Society of Hematology, which wraps up Tuesday, Novartis, Celgene and Seattle Genetics revealed the latest news from their studies on blood diseases and cancers. But despite some positi…
After 80 years of tech achievements, Motorola has run into a nemesis unlike others it has overcome in the past. And it’s not for lack of trying. Even as Motorola restructures and launches new products, it keeps getting upstaged…
After 80 years of tech achievements, Motorola has run into a nemesis unlike others it has overcome in the past. And it’s not for lack of trying. Even as Motorola restructures and launches new products, it keeps getting upstaged…
When Barnes & Noble announced it was looking for a buyer, we entertained the fanciful notion that struggling rival Borders might put in a bid. As absurd as the idea was, that buyout offer has been made. Here’s why it has virtua…
When Barnes & Noble announced it was looking for a buyer, we entertained the fanciful notion that struggling rival Borders might put in a bid. As absurd as the idea was, that buyout offer has been made. Here’s why it has virtua…